Morgan Stanley’s Addex Therapeutics ADXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$941	Hold	100	–	–	﹤0.01%	7340
2025 Q1	$734	Sell	100 -1,800	-95%	-$13.2K	﹤0.01%	7324
2024 Q4	$13.3K	Buy	1,900 +1,547	+438%	+$10.8K	﹤0.01%	6703
2024 Q3	$3.45K	Sell	353 -1,147	-76%	-$11.2K	﹤0.01%	7007
2024 Q2	$12.3K	Buy	+1,500	New	+$12.3K	﹤0.01%	6609